These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19949424)

  • 1. Role of Esrrg in the fibrate-mediated regulation of lipid metabolism genes in human ApoA-I transgenic mice.
    Sanoudou D; Duka A; Drosatos K; Hayes KC; Zannis VI
    Pharmacogenomics J; 2010 Jun; 10(3):165-79. PubMed ID: 19949424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
    Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
    Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
    Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.
    Rotllan N; Llaverías G; Julve J; Jauhiainen M; Calpe-Berdiel L; Hernández C; Simó R; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2011 Feb; 1811(2):104-10. PubMed ID: 21126601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate.
    Bouly M; Masson D; Gross B; Jiang XC; Fievet C; Castro G; Tall AR; Fruchart JC; Staels B; Lagrost L; Luc G
    J Biol Chem; 2001 Jul; 276(28):25841-7. PubMed ID: 11342537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein.
    Lie J; Lankhuizen IM; Gross B; van Gent T; van Haperen R; Scheek L; Staels B; de Crom R; van Tol A
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):48-53. PubMed ID: 16298159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
    J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
    Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
    J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes.
    Warren JM; Simon VA; Bartolini G; Erickson KL; Mackey BE; Kelley DS
    Lipids; 2003 May; 38(5):497-504. PubMed ID: 12880104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.
    Duez H; Chao YS; Hernandez M; Torpier G; Poulain P; Mundt S; Mallat Z; Teissier E; Burton CA; Tedgui A; Fruchart JC; Fiévet C; Wright SD; Staels B
    J Biol Chem; 2002 Dec; 277(50):48051-7. PubMed ID: 12377786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
    Dueland S; France D; Wang SL; Trawick JD; Davis RA
    J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element.
    Vu-Dac N; Schoonjans K; Laine B; Fruchart JC; Auwerx J; Staels B
    J Biol Chem; 1994 Dec; 269(49):31012-8. PubMed ID: 7983038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.
    Morishima A; Ohkubo N; Maeda N; Miki T; Mitsuda N
    J Biol Chem; 2003 Oct; 278(40):38188-93. PubMed ID: 12882972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice.
    Tietge UJ; Maugeais C; Lund-Katz S; Grass D; deBeer FC; Rader DJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1213-8. PubMed ID: 12117740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice.
    Weinstock PH; Bisgaier CL; Hayek T; Aalto-Setala K; Sehayek E; Wu L; Sheiffele P; Merkel M; Essenburg AD; Breslow JL
    J Lipid Res; 1997 Sep; 38(9):1782-94. PubMed ID: 9323588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice.
    Lu Y; Boekschoten MV; Wopereis S; Müller M; Kersten S
    Physiol Genomics; 2011 Dec; 43(23):1307-18. PubMed ID: 21954454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.
    van der Hoogt CC; de Haan W; Westerterp M; Hoekstra M; Dallinga-Thie GM; Romijn JA; Princen HM; Jukema JW; Havekes LM; Rensen PC
    J Lipid Res; 2007 Aug; 48(8):1763-71. PubMed ID: 17525476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of experimental nephrosis on hepatic lipoprotein secretion and urinary lipoprotein excretion in rats expressing the human apolipoprotein A-I gene.
    Marsh JB; Diffenderfer MR; Fisher EA; Sowden M; Dong M; Paterniti JR; Burkey BF
    J Lipid Res; 1996 May; 37(5):1113-24. PubMed ID: 8725162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.